We are live on ! Find out more
FOLD

Amicus Therapeutics

Delisted

FOLD was delisted on the 24th of April, 2026.

134 hedge funds and large institutions have $1.2B invested in Amicus Therapeutics in 2017 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding in top 10

Funds holding in top 10: 47 (+3)

54% more capital invested

Capital invested by funds: $780M → $1.2B (+$424M)

27% more call options, than puts

Call options by funds: $9.28M | Put options by funds: $7.29M

22% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 23

21% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 39

8.05% more ownership

Funds ownership: 110.21%118.25% (+8%)

1% less funds holding

Funds holding: 135134 (-1)

Holders
134
Holders Change
-1
Holders Change %
-0.74%
% of All Funds
3.33%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.17%
New
28
Increased
47
Reduced
39
Closed
23
Calls
$9.28M
Puts
$7.29M
Net Calls
+$2M
Net Calls Change
-$8.26M
Name Holding Trade Value Shares
Change
Change in
Stake
HT
76
HAP Trading
New York
$416K +$369K +58,309 New
Invesco
77
Invesco
Georgia
$404K +$358K +56,647 New
TMAM
78
Tokio Marine Asset Management
Japan
$399K +$353K +55,900 New
TRSOTSOK
79
Teachers Retirement System of the State of Kentucky
Kentucky
$396K
State Board of Administration of Florida Retirement System
80
State Board of Administration of Florida Retirement System
Florida
$394K
Legal & General Group
81
Legal & General Group
United Kingdom
$390K -$3.46K -548 -1%
VOYA Investment Management
82
VOYA Investment Management
Georgia
$386K -$10.1M -1,600,440 -97%
Jane Street
83
Jane Street
New York
$377K +$176K +27,823 +111%
ARTA
84
A.R.T. Advisors
New York
$365K +$324K +51,200 New
UBS AM
85
UBS AM
Illinois
$361K +$134K +21,174 +72%
KCM
86
Knoll Capital Management
Florida
$357K +$316K +50,000 New
Squarepoint
87
Squarepoint
New York
$343K -$127K -20,072 -29%
VEA
88
Virtus ETF Advisers
New York
$341K +$29K +4,587 +11%
CA
89
Corrado Advisors
New Jersey
$339K +$43.2K +6,825 +17%
Citigroup
90
Citigroup
New York
$282K -$1.55M -245,040 -86%
Brown Advisory
91
Brown Advisory
Maryland
$227K -$1.92K -304 -0.9%
TCM
92
Traynor Capital Management
Pennsylvania
$223K +$186K +29,346 New
Simplex Trading
93
Simplex Trading
Illinois
$214K +$191K +30,131 New
Public Employees Retirement Association of Colorado
94
Public Employees Retirement Association of Colorado
Colorado
$198K
SSA
95
Schonfeld Strategic Advisors
New York
$197K +$175K +27,611 New
Principal Financial Group
96
Principal Financial Group
Iowa
$192K +$3.08K +487 +2%
HCMT
97
Highland Capital Management (Texas)
Texas
$178K -$82.2K -13,000 -34%
OC
98
Oppenheimer & Co
New York
$167K -$111K -17,584 -43%
SG Americas Securities
99
SG Americas Securities
New York
$160K -$228K -36,035 -62%
CI
100
Cowen Inc
New York
$150K +$133K +21,000 New

FOLD Hedge Fund Activity: Q1 2017 in Review

134 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q1 2017, worth a combined $1.2B — up 54% from $780M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new FOLD positions and 23 closed out — a net gain of 5 holders — while 47 added to existing stakes and 39 trimmed.

The largest buyer was BlackRock, adding an estimated $75.6M. The largest seller was AllianceBernstein, cutting an estimated $10.3M.

  • 134 institutional investors held Amicus Therapeutics (FOLD) as of Q1 2017, down from 135 in Q4 2016.
  • Funds reported $1.2B of Amicus Therapeutics stock for Q1 2017, up 54% quarter-over-quarter.
  • 28 funds opened new Amicus Therapeutics positions in Q1 2017 and 23 closed out, a net change of +5 holders.
  • The largest Amicus Therapeutics buyer in Q1 2017 was BlackRock, an estimated $75.6M added.
  • The largest Amicus Therapeutics seller in Q1 2017 was AllianceBernstein, an estimated $10.3M sold.

Based on aggregated 13F filings for Q1 2017.